Treatment for Vestibular Hypofunction

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Montana, Missoula, MT
Vestibular Hypofunction
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The proposed research is relevant to vestibular science and the general public because age-related vestibular hypofunction is a major contributor to poor balance, falls, and other adverse health outcomes. In this investigation the investigators will: 1) assess the preliminary efficacy of a novel intervention system for improving vestibular function and dizziness in community-dwelling older adults, 2) assess the safety and feasibility of the this system, and 3) assess the acceptability and implementation potential of this system, prior to a large-scale, R01-level investigation.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Vestibular Hypofunction

Study Objectives

1 Primary · 6 Secondary · Reporting Duration: through study completion, an average of 12 weeks

Week 12
Activities-specific Balance Confidence Scale (ABC)
Community Ambulatory Task (CAT)
Computerized Dynamic Visual Acuity (cDVA)
Dizziness Handicap Inventory (DHI)
Functional Gait Assessment (FGA)
General Well Being Scale
Instrumented postural sway assessment
Life Space Mobility Assessment (LSA)
Mini- Balance Evaluation Systems Test (BESTest)
National Aeronautics and Space Administration (NASA) task load index
Physical Activity Tracker
Role Participation Questionnaire
System Usability Scale
Two minute walk test (2MWT)
Video head impulse testing (vHIT)
Visual Analog Scale of Dizziness and Unsteadiness

Trial Safety

Safety Progress

1 of 3

Other trials for Vestibular Hypofunction

Trial Design

0 Treatment Group

36 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 12 weeks

Trial Background

Prof. Brian Loyd, Professor
Principal Investigator
University of Montana
Closest Location: University of Montana · Missoula, MT
2009First Recorded Clinical Trial
1 TrialsResearching Vestibular Hypofunction
10 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a history of peripheral vestibular hypofunction.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.